menu
    • menu

    Company profile for IASO Bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases. Leveraging its proprietary fully human antibody discovery platform (IMARS), high-throughput CAR-T drug priority platform, and proprietary manufacturing processes, IASO Bio is developing a rich clinical-stage pipeline of multiple autologous and allogeneic CAR-T and biologi...
    IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases. Leveraging its proprietary fully human antibody discovery platform (IMARS), high-throughput CAR-T drug priority platform, and proprietary manufacturing processes, IASO Bio is developing a rich clinical-stage pipeline of multiple autologous and allogeneic CAR-T and biologics product candidates. Currently, the company is developing a diversified portfolio of over 10 novel pipeline products. ASO’s leading asset, CT103A, an innovative anti-BCMA CAR T- cell therapy

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IASO BioChina Flag
    Country
    Country
    China
    Address
    Address
    floor 8-10, building D, zhongdanyuan, 3-1 xinjinhu road, jiangbei new distric...
    Telephone
    Telephone
    025-58287610
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.iasobio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hong Kong Approves IASO Bio's Fucaso for R/R Myeloma
    Hong Kong Approves IASO Bio's Fucaso for R/R Myeloma

    27 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-announces-bla-approval-of-fucaso-equecabtagene-autoleucel-by-the-hong-kong-department-of-health-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma-302627345.html

    PR NEWSWIRE
    27 Nov 2025
    Share Share
    IASO Bio Partners With GC Cell For CAR-T Therapy In Korea
    IASO Bio Partners With GC Cell For CAR-T Therapy In Korea

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-partners-with-koreas-gc-cell-to-bring-car-t-therapy-to-korea-302598178.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    IASO Bio’s Anti-GPRC5D CAR-T RD118 Shows Promise in R/R Myeloma
    IASO Bio’s Anti-GPRC5D CAR-T RD118 Shows Promise in R/R Myeloma

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blood-publishes-promising-results-of-iaso-bios-anti-gprc5d-car-t-rd118-in-relapsedrefractory-multiple-myeloma-302591431.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    IASO Bio Gets Japan Approval For BCMA CAR-T Trial
    IASO Bio Gets Japan Approval For BCMA CAR-T Trial

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-announces-approval-of-clinical-trial-notification-for-its-bcma-car-t-product-in-japan-302590051.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    Cell Reports IASO Bio's Anti-BCMA CAR-T For MS
    Cell Reports IASO Bio's Anti-BCMA CAR-T For MS

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cell-publishes-breakthrough-research-results-of-iaso-bios-anti-bcma-car-t-equecabtagene-autoleucel-in-autoimmune-disease-multiple-sclerosis-302586317.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    IASO Bio Presents 3-Year Follow-Up Data on Fucaso CAR-T Therapy
    IASO Bio Presents 3-Year Follow-Up Data on Fucaso CAR-T Therapy

    18 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/2025-ims--iaso-bio-highlights-three-year-follow-up-data-of-car-t-cell-therapy-fucaso-for-multiple-myeloma-treatment-302561198.html

    PR NEWSWIRE
    18 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search